JJ Kang

JJ Kang, Ph.D., is co-founder and CEO. She is a venture partner at The Column Group since 2020 and serves on the boards of directors of Tenaya Therapeutics and Escient Pharmaceuticals. JJ held roles of increasing responsibility on the investment team at The Column Group since joining in 2015 and last served as a partner prior to joining Appia Bio. Previously, she worked at FibroGen in project management and corporate strategy. JJ earned a PhD in chemical biology at Caltech and a BA in chemistry from Harvard University.